Eli Lilly Migraine Drug Approved and Will Be Free to Patients

(Bloomberg) -- Eli Lilly & Co. got clearance from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painfu...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.